Editorial: Current trends and future perspectives about liquid biopsy

Front Genet. 2023 Dec 14:14:1345876. doi: 10.3389/fgene.2023.1345876. eCollection 2023.

Elisa Frullanti^{1

2}, María José Serrano^{3

4

5}

¹ Cancer Genomics and Systems Biology Laboratory, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
² Department of Medical Biotechnologies, Med Biotech Hub and Competence Centre, University of Siena, Siena, Italy.
³ GENYO Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Liquid Biopsy and Cancer Interception Group, PTS Granada, Granada, Spain.
⁴ Biomedical Research Institute IBS-Granada, Granada, Spain.
⁵ Integral Oncology Division, Virgen de las Nieves University Hospital, Granada, Spain.

No abstract available

Keywords: cancer biomarkers; circulating cancer molecules; disease monitoring; human cancer; liquid biopsy.

Publication types

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.